Sanara MedTech Inc. (SMTI) Cash Flow Statement
Sanara MedTech Inc. (SMTI) generated $5.7M of operating cash flow over the twelve months to 2026-06-30, spent $1.2M on capital expenditure and had free cash flow of $4.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SMTISanara MedTech Inc.Follow SMTI — free
—
Price chart with a free account
- Market cap
- 301.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.3 | -1.2 | -1.8 | -1.7 | -1.2 | 0.4 | -0.1 | 0.3 | -2.2 | -4.0 | -4.8 | -5.6 | -3.2 | -0.0 | 6.8 | 5.7 | |
| Capital expenditure | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.5 | 0.2 | 0.1 | 0.3 | 0.2 | 4.6 | -1.2 | |
| Free cash flow | — | — | -1.9 | -1.7 | -1.2 | 0.4 | -0.2 | 0.3 | -2.4 | -4.6 | -5.0 | -5.7 | -3.5 | -0.2 | 2.2 | 4.5 | |
| Stock-based compensation | — | — | — | — | — | — | — | — | — | 1.4 | 2.7 | 2.7 | 3.4 | 4.4 | 5.2 | — |
USD millions · SEC XBRL
Sanara MedTech Inc. — questions
- What is Sanara MedTech Inc.'s operating cash flow?
- $5.7M over the twelve months to 2026-06-30.
- How much does Sanara MedTech Inc. spend on capital expenditure?
- $1.2M over the twelve months to 2026-06-30.
- What is Sanara MedTech Inc.'s free cash flow?
- $4.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Sanara MedTech Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.